Diabetes mellitus: Plasticizers and nanomaterials acting as endocrine-disrupting chemicals (Review)

被引:23
|
作者
Tuculina, Mihaela Jana [1 ]
Perlea, Paula [2 ]
Gheorghita, Mircea [1 ]
Cumpata, Cristian Niky [3 ]
Dascalu, Ionela Teodora [1 ]
Turcu, Adina [1 ]
Nicola, Andreea Gabriela [1 ]
Gheorghita, Lelia Mihaela [1 ]
Diaconu, Oana Andreea [1 ]
Valea, Ana [4 ]
Ghemigian, Adina [5 ,6 ]
Carsote, Mara [5 ,6 ]
机构
[1] Univ Med & Pharm Craiova, Fac Dent Med, Dept Orthodont, 2-4 Petru Rares St, Craiova 200349, Romania
[2] Carol Davila Univ Med & Pharm, Fac Dent Med, Dept Endodontol, 17-23 Calea Plevnei St, Bucharest 050474, Romania
[3] Titu Maiorescu Univ Bucharest, Fac Dent Med, Bucharest 031593, Romania
[4] Iuliu Hatieganu Univ Med & Pharm, Dept Endocrinol, Cluj Napoca 400337, Romania
[5] Carol Davila Univ Med & Pharm, Dept Endocrinol, Bucharest 020021, Romania
[6] CI Parhon Natl Inst Endocrinol, Dept Endocrinol, Bucharest 011863, Romania
关键词
plasticizers; nanomaterial; endocrine disruptors; diabetes mellitus; phthalates; bisphenol A; BISPHENOL-A; SELENIUM NANOPARTICLES; ORAL DELIVERY;
D O I
10.3892/etm.2022.11217
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Various plasticizers and nanomaterials have been linked to endocrine disruptors or endocrine-disrupting chemicals (EDCs) which represent a large, heterogeneous, yet incompletely understood group of structures acting on normal and pathological body pathways such as hormonal production, secretion, transport and receptor binding. By contrast, various applications of nanoparticles are currently under investigation since the delivery of useful drugs, particularly insulin in diabetes mellitus, is essential in case of insulin deficiency. The aim of the present review was to introduce and examine different plasticizers and nanomaterials with potential applications for diabetic patients (such as selenium or gold-based nanoparticles that help the oral delivery of insulin) or plasticizers/nanomaterials acting similarly to EDCs in relation to the human and animal body, particularly glucose metabolism impairment such as diabetes mellitus (DM). Bisphenol A is a chemical used worldwide; however, the effect of exposure varies with regard to the source, environment, time of exposure and the age of the organism. Daily exposure is mostly related to food and drinks stored in polycarbonate plastics. However, exposure may also be through the skin or through the maternal placenta or breast milk which are risk factors for the fetus and for the newborn. It exerts an estrogen-like profile, but it also induces insulin resistance by impairing peripheral insulin receptors or it decreases insulin secretion by acting at the level of insulin-secreting pancreatic beta-cells. Phthalates, compounds of flexible plastics, act as EDCs via their human metabolites such as diethyl phthalate and derivative monoethyl phthalate. Their role in inducing gestational DM and weight gain/obesity during pregnancy has been showcased. The vast field of plasticizers and nanomolecules acting as endocrine disruptors is widely linked to clinical aspects of DM, a serious condition with a major population impact. The importance of understanding and using these agents and applications is reflected in saving numerous human lives.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis
    Yan, Dandan
    Jiao, Yang
    Yan, Honglin
    Liu, Tian
    Yan, Hong
    Yuan, Jingping
    [J]. ENVIRONMENTAL HEALTH, 2022, 21 (01)
  • [2] Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis
    Dandan Yan
    Yang Jiao
    Honglin Yan
    Tian Liu
    Hong Yan
    Jingping Yuan
    [J]. Environmental Health, 21
  • [3] Effects of Endocrine-Disrupting Chemicals on Obesity and Diabetes
    Cander, Soner
    Yetkin, Ilhan
    [J]. ENDOCRINOLOGY RESEARCH AND PRACTICE, 2023, 27 (04): : 233 - 240
  • [4] Role of Endocrine-Disrupting Engineered Nanomaterials in the Pathogenesis of Type 2 Diabetes Mellitus
    Priyam, Ayushi
    Singh, Pushplata Prasad
    Gehlout, Shweta
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [5] Endocrine-Disrupting Chemicals
    Gore, Andrea C.
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (11) : 1705 - 1706
  • [6] Endocrine-disrupting chemicals
    Kiess, Wieland
    Haeusler, Gabriele
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (05)
  • [7] Endocrine-disrupting chemicals
    Bertram, Michael G.
    Gore, Andrea C.
    Tyler, Charles R.
    Brodin, Tomas
    [J]. CURRENT BIOLOGY, 2022, 32 (13)
  • [8] Endocrine-Disrupting Chemicals
    Friedrich, M. J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (15): : 1578 - 1578
  • [9] Exposure to Endocrine-Disrupting Chemicals and Type 2 Diabetes Mellitus in Later Life
    Jian-Yan Lin
    Rui-Xing Yin
    [J]. Exposure and Health, 2023, 15 : 199 - 229
  • [10] Exposure to Endocrine-Disrupting Chemicals and Type 2 Diabetes Mellitus in Later Life
    Lin, Jian-Yan
    Yin, Rui-Xing
    [J]. EXPOSURE AND HEALTH, 2023, 15 (01) : 199 - 229